Current stock page

Stock Analysis

Disc Medicine, Inc. (IRON) Stock Analysis

Disc Medicine, Inc. (IRON) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

IRON Stock Analysis Summary

Disc Medicine, Inc. (IRON) currently has an AIQ Score of 65/100, indicating a bullish setup. Momentum is the strongest factor at 75/100. Risk is the weakest current factor at 51/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

IRON at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$80.00
AIQ Score65/100
Overall ViewBullish
Technical Analysis ConsensusBuy
Market Cap$3.11B
P/E Ratio (TTM)-12.58
Forward P/E—
EPS (Q3 FY2026)-$1.53
Revenue (Q3 FY2026)$0
Dividend Yield (TTM)0.00%
Beta0.99
Volume779.95K
52-week range$40.00-$99.50
RSI 1454.17
50-Day SMA$71.59
200-Day SMA$70.95
Analyst Price Target$127.14
Next EarningsFeb 25, 2027
As of Nov 13, 2026 · Market close

IRONDisc Medicine, Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$80.00−$3.23 (−3.88%)

Latest quote

  • Momentum
    75
  • Value
    —
  • Quality
    60
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

IRON Stock Analysis Summary

Disc Medicine, Inc. (IRON) currently has an AIQ Score of 65/100, indicating a bullish setup. Momentum is the strongest factor at 75/100. Risk resilience is the weakest current factor at 51/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, IRON has AIQ Score of 65/100 with Momentum base of 75/100 and fading Risk resilience at 51/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (75/100) leads while Risk resilience (51/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -3.88% stock move · IRON classified in Biotechnology.

Current Evidence

BullishIRON is in a bullish AIQ regime; Momentum is the strongest visible factor at 75/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is IRON Bullish or Bearish Right Now?

IRON currently has a bullish overall setup. Momentum is the strongest factor at 75/100, while Risk Resilience is weakest at 51/100. The current evidence suggests a constructive setup.

Bull Case
  • - Momentum is constructive at 75/100.
  • - Price is +11.74% above its 50-day SMA.
  • - Analyst target implies +58.93% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (28 vs 10).
Bear Case
  • - No strong bearish evidence is available in the current snapshot.

Current Consensus

IRON's Technical Analysis Consensus is currently Buy, with 28 buy, 8 neutral, and 10 sell votes. IRON's 14-day RSI is 54.17, which places the stock in a neutral momentum range. IRON's beta is 0.99, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in IRON?

The largest recent change in IRON is Momentum moving down by 2.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-1.0
Momentum
-2.0
Quality
+0.0
Risk
+0.0

What Would Change the IRON Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

IRON Decision Framework

Public evidence layers, setup checks, and risk context for Disc Medicine, Inc..

Disc Medicine, Inc. (IRON) Stock Analysis

Disc Medicine, Inc. has an AIQ Score of 65/100 in a Bullish regime. Momentum is strongest at 75/100. Beta is 0.99, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextIRON is in a Bullish AIQ regime with score 65/100.
Signal ConflictThe primary conflict is that momentum leads at 75/100 while risk lags at 51/100.
Factor EvidenceMomentum 75/100 · Quality 60/100 · Risk 51/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 75/100.

TimingPass

Momentum is 75/100 and RSI (14) is 54.2.

Regime fitPass

IRON is in a Bullish regime at 65/100.

Risk controlWait

Risk factor is 51/100 with beta 0.99 and annual volatility 63.55%.

ConflictWait

Current conflict: momentum leads at 75/100 while risk lags at 51/100.

AIQ Score
65/100
Price
$80.00
Beta
0.99
RSI (14)
54.2

IRON Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

IRON Fundamentals

IRON valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$0
Net income
-$59.54M
Free cash flow
-$40.2M
View full IRON fundamental analysis

IRON Technical Analysis

IRON technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Buy
RSI 14
54.17
Price vs SMA-50
+11.74%
View full IRON technical analysis

IRON Stock Catalysts

Track IRON earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 25, 2027
Analyst target
$127.14
News items
0
View IRON earnings and stock catalysts

IRON Dividend Analysis

IRON dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View IRON dividend history and analysis

IRON Financial Data

IRON revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$0
EPS
-$1.53
Periods
8
View IRON financials

IRON Risk Analysis

IRON volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.99
Risk score
51/100
1Y volatility
63.55%
View IRON risk analysis

IRON Stock News

IRON stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read IRON stock news

IRON vs Biotechnology Peers

Current peer cohort: IRON · JAZZ · KOD · KRYS · KURA. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
IRON
Current stock
65/100—75/10051/1000.163.55%Current
JAZZ
Jazz Pharmaceuticals plc
73/10079/10066/10073/1001.4738.64%IRON vs JAZZ
KOD
Kodiak Sciences Inc.
52/100—91/10044/1001.43205.61%IRON vs KOD
KRYS
Krystal Biotech, Inc.
69/10067/10058/10069/1001.1639.38%IRON vs KRYS
KURA
Kura Oncology, Inc.
47/10070/10040/10039/100-0.2563.01%IRON vs KURA
Pairwise Compare links: JAZZ · KOD · KRYS · KURAIRON vs JAZZIRON vs KODIRON vs KRYSIRON vs KURACompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a IRON stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for IRON: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-12.58
As of Nov 13, 2026
Revenue growth
—
Gross margin
0.00%
Current debt / equity
0.1
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$0
Quarter net income
-$59.54M
Quarter free cash flow
-$40.2M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Mixed
RSI 14
54.17
MACD
3.56

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
51/100
Beta
0.99
Annual volatility
63.55%
Max drawdown
-40.77%

IRON Stock FAQ

What is IRON stock price today?

Disc Medicine, Inc.'s current stock price is $80.00. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is IRON bullish or bearish right now?

IRON's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is IRON's market cap?

IRON's market cap is $3.11B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is IRON's current P/E ratio?

IRON's current P/E ratio is -12.58 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is IRON's RSI?

IRON's 14-day RSI is 54.17 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is IRON above its 50-day and 200-day moving averages?

IRON is 11.74% from its 50-day SMA and 12.76% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is IRON's next earnings date?

IRON's next earnings date is currently listed as Feb 25, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does IRON pay a dividend?

IRON's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.